Monday, January 16, 2017

BRIEF-Idogen: Orphan drug designation formally granted for Idogen in Europe

* Says the European Commission formally has granted Idogen's

orphan drug designation for the treatment of patients with

hemophilia A in Europe

Read more
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)